MARKET

VRML

VRML

Vermillion
NASDAQ

Real-time Quotes | Nasdaq Last Sale

0.7800
-0.0058
-0.74%
Closed 16:00 04/03 EDT
OPEN
0.8188
PREV CLOSE
0.7858
HIGH
0.8188
LOW
0.7600
VOLUME
502.62K
TURNOVER
--
52 WEEK HIGH
1.570
52 WEEK LOW
0.3506
MARKET CAP
75.88M
P/E (TTM)
-4.2740
1D
5D
1M
3M
1Y
5Y

Analyst Rating

Based on 1 analysts

Hold

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

Analyst Price Target

The average VRML stock price target is 1.000 with a high estimate of 1.000 and a low estimate of 1.000.

EPS

VRML News

More
  • Edited Transcript of VRML earnings conference call or presentation 26-Mar-20 8:30pm GMT
  • Thomson Reuters StreetEvents · 1h ago
  • Vermillion inks national preferred contract with Cigna
  • seekingalpha · 03/27 17:10
  • Vermillion Announces Cigna Preferred Contract Coverage for OVA1, Overa and Genetics Testing
  • GlobeNewswire · 03/27 13:00
  • Vermillion reports Q4 results
  • seekingalpha · 03/27 01:02

Industry

Biotechnology & Medical Research
-0.51%
Pharmaceuticals & Medical Research
-0.22%

Hot Stocks

Symbol
Price
%Change

About VRML

Vermillion, Inc. is a diagnostic service and bio-analytic solutions provider. The Company is engaged in the business of developing and commercializing diagnostic tests for gynecologic disease. It sells OVA1 risk of malignancy test for pelvic mass disease (OVA1). OVA1 is a blood test designed to, in addition to a physician's clinical assessment of a woman with a pelvic mass, identify women who are at risk of having a malignant ovarian tumor prior to planned surgery. It developed OVA1 through pre-clinical studies in collaboration with various academic medical centers encompassing over 2,500 clinical samples. OVA1 is validated in a multi-center clinical trial encompassing approximately 30 sites reflective of the diverse nature of the clinical centers, at which ovarian adnexal masses are evaluated. Its ASPiRA LABS is a laboratory that provides diagnostic services using a biomarker-based diagnostic algorithm to inform clinical decision making and personalized treatment plans.
More

Webull offers kinds of Vermillion, Inc. stock information, including NASDAQ:VRML real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, VRML stock news, and many more online research tools to help you make informed decisions.